These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23849252)

  • 1. Quality of frozen transfusable plasma prepared from whole blood donations in Canada: an update.
    Sheffield WP; Bhakta V; Talbot K; Pryzdial EL; Jenkins C
    Transfus Apher Sci; 2013 Dec; 49(3):440-6. PubMed ID: 23849252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion to the buffy coat method and quality of frozen plasma derived from whole blood donations in Canada.
    Sheffield WP; Bhakta V; Jenkins C; Devine DV
    Transfusion; 2010 May; 50(5):1043-9. PubMed ID: 20070616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada.
    Sheffield WP; Bhakta V; Howell A; Jenkins C; Serrano K; Johnson N; Lin YJ; Colwill K; Rathod B; Greenberg B; Gingras AC; Evans DH; Flaumenhaft E; Beckett A; Drews SJ; Devine DV
    Transfusion; 2022 Feb; 62(2):418-428. PubMed ID: 34907536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fresh frozen plasma quality: relation to age and gender of blood donors.
    Madla W; Alt T; Jungk H; Bux J
    Vox Sang; 2012 Feb; 102(2):116-24. PubMed ID: 21752027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Thawed Apheresis Fresh-Frozen Plasma Stored for up to 120 Hours at 1°C to 6°C.
    Sheffield WP; Bhakta V; Yi QL; Jenkins C
    J Blood Transfus; 2016; 2016():6260792. PubMed ID: 28003931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium.
    Zeller MP; Al-Habsi KS; Golder M; Walsh GM; Sheffield WP
    Transfus Med Rev; 2015 Jul; 29(3):181-94. PubMed ID: 25862281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing.
    Sheffield WP; Bhakta V; Mastronardi C; Ramirez-Arcos S; Howe D; Jenkins C
    Transfusion; 2012 Mar; 52(3):493-502. PubMed ID: 21883262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
    Hellstern P
    Transfus Apher Sci; 2008 Aug; 39(1):69-74. PubMed ID: 18583192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery.
    Haubelt H; Blome M; Kiessling AH; Isgro F; Bach J; Saggau W; Hellstern P
    Vox Sang; 2002 Jan; 82(1):9-14. PubMed ID: 11856461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of whole blood processing and freezing conditions on the quality of therapeutic plasma prepared from whole blood.
    Runkel S; Hitzler WE; Hellstern P
    Transfusion; 2015 Apr; 55(4):796-804. PubMed ID: 25371048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood.
    Runkel S; Haubelt H; Hitzler W; Hellstern P
    Transfusion; 2005 Mar; 45(3):427-32. PubMed ID: 15752162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
    Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
    Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
    Beck KH; Mortelmans Y; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the pre-processing holding time of whole blood beyond 48 h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma.
    Sheffield WP; Bhakta V; Jenkins C
    Transfus Apher Sci; 2018 Dec; 57(6):768-772. PubMed ID: 30266202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels.
    Alesci S; Borggrefe M; Dempfle CE
    Thromb Res; 2009 May; 124(1):121-6. PubMed ID: 19128820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
    Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
    Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.
    Lu FQ; Kang W; Peng Y; Wang WM
    Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.